Background: Notch1 has been linked to the pathogenesis of asthma due to its contribution on Th1/Th2 imbalance. γ-Secretase inhibitor (GSI) acts as an effective blocker of Notch1 signaling. Glucocorticoids (GCs) are the most effective anti-inflammatory drugs for asthma. The present study investigated the involvement of the Notch1 pathway in the anti-inflammatory effect of GCs and its association with Th1/Th2 balance. Methods: The asthma model was established in BALB/c mice by sensitization with ovalbumin (OVA). Dexamethasone (DEX; 1 mg/kg) and/or GSI (0.03 mg/kg) was orally or intranasally administrated. Results: Compared to the OVA-sensitized mice, the administration of DEX and/or GSI significantly ameliorated the airway inflammation infiltration, goblet cell metaplasia, and airway hyper-responsiveness. The expression of IL-4 and IL-13, as well as the ratios of eosinophils and lymphocytes, were significantly decreased, whereas IFN-γ and IL-2 levels were significantly increased in bronchoalveolar lavage fluid after the administration of DEX and GSI. The expressions of the Notch1/NICD1 pathway were decreased after DEX and/or GSI administration in lung tissues, especially in CD4+ T cells. Also, a reduction of GATA3 and elevation of T-bet levels were correlated with the upregulation of Th1/Th2 ratios in lung tissues. Conclusions: Through the inhibition of Notch1 signaling, both GSI and GCs could regulate Th1/Th2 balance involved in allergic airway inflammation in OVA-induced asthma.

Keywords:
Asthma, Glucocorticoid, Notch signaling, γ-Secretase inhibitor
1.
Long H: Esculetin attenuates Th2 and Th17 responses in an ovalbumin-induced asthmatic mouse model. Inflammation 2016;39:735-743.
2.
Zhou M, Cui ZL, Guo XJ, Ren LP, Yang M, Fan ZW, Han RC, Xu WG: Blockade of Notch signaling by γ-secretase inhibitor in lung T Cells of asthmatic mice affects T cell differentiation and pulmonary inflammation. Inflammation 2015;38:1281-1288.
3.
Kang JH, Kim BS, Uhm TG, Lee SH, Lee GR, Park CS, Chung IY: γ-Secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. Am J Resp Crit Care 2009;179:875-882.
4.
Effros RM, Nagaraj H: Asthma: new developments concerning immune mechanisms, diagnosis and treatment. Curr Opin Pulm Med 2007;13:37-43.
5.
Emmanuel O, Andrew CBC: Effects of glucocorticoids in the immune system; in Wang JC, Harris C (eds): Glucocorticoid Signaling: From Molecule to Mice to Man. New York, Springer, 2015, vol 872, pp 217-233.
6.
Zhang W, Nie Y, Chong L, Cai X, Zhang H, Lin B, Liang Y, Li C: PI3K and Notch signal pathways coordinately regulate the activation and proliferation of T lymphocytes in asthma. Life Sci 2013;92:890-895.
7.
Wu Q, Tang Y, Hu X, Wang Q, Lei W, Zhou L, Huang J: Regulation of Th1/Th2 balance through OX40/OX40L signaling by glycyrrhizic acid in a murine model of asthma. Respirology 2016;21:102-111.
8.
Amsen D, Antov A, Flavell RA: The different faces of Notch in T-helper-cell differentiation. Nat Rev Immunol 2009;9:116-124.
9.
Wakabayashi N, Chartoumpekis DV, Kensler TW: Crosstalk between Nrf2 and Notch signaling. Free RadicBiol Med 2015;88:158-167.
10.
Ayaz F, Osborne BA: Non-canonical Notch signaling in cancer and immunity. Front Oncol 2014;4:345.
11.
Maillard I, Fang T, Pear WS: Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 2005;23:945-974.
12.
Amsen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, Busslinger M, McCright B, Gridley T, Flavell RA: Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 2007;27:89-99.
13.
Pei J, Tang Z, Zang G, Yu Y: Blockage of Notch1 signaling modulates the T-helper (Th)1/Th2 cell balance in chronic hepatitis B patients. Hepatol Res 2010;40:799-805.
14.
Guo XJ, Zhou M, Ren LP, Yang M, Huang SG, Xu WG: Small interfering RNA-mediated knockdown of Notch1 in lung. Chin Med J 2009;122:2647-2651.
15.
Wang N, Yan D, Liu Y, Liu Y, Gu X, Sun J, Long F, Jiang S: A HuR/TGF-β1 feedback circuit regulates airway remodeling in airway smooth muscle cells. Respir Res 2016;17:117.
16.
Liu R, Bai J, Xu G, Xuan L, Zhang T, Meng A, Hou Q: Multi-allergen challenge stimulates steroid-resistant airway inflammation via NF-κB-mediated IL-8 expression. Inflammation 2013;36:845-854.
17.
Wang J, Wu J, Kong L, Nurahmat M, Chen M, Luo Q, Li B, Wu X, Dong J: BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice. J Ethnopharmacol 2014;154:131-147.
18.
Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD: Asthma. Nat Rev Dis Primers 2015;1:15025.
19.
Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA: Instruction of distinct CD4 T helper cell fates by different Notch ligands on antigen-presenting cells. Cell 2004;117:515-526.
20.
Okamoto M, Matsuda H, Joetham A, Lucas JJ, Domenico J, Yasutomo K, Takeda K, Gelfand EW: Jagged1 on dendritic cells and Notch on CD4+ T cells initiate lung allergic responsiveness by inducing IL-4 production. J Immunol 2009;183:2995-3003.
21.
Amsen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, Busslinger M, McCright B, Gridley T, Flavell RA: Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 2007;27:89-99.
22.
Minter LM, Turley DM, Das P, Shin HM, Joshi I, Lawlor RG, Cho OH, Palaga T, Gottipati S, Telfer JC, Kostura L, Fauq AH, Simpson K, Such KA, Miele L, Golde TE, Miller SD, Osborne BA: Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol 2005;6:680-688.
23.
Gu W, Xu W, Ding T, Guo X: Fringe controls Naïve CD4+T cells differentiation through modulating Notch signaling in asthmatic rat models. PLoS One 2012;7:e47288.
24.
Barnes PJ, Adcock IM: How do corticosteroids work in asthma? Ann Intern Med 2003;139:359-370.
25.
Ram A, Mabalirajan U, Jaiswal A, Rehman R, Singh VP, Ghosh B: Parabromophenacyl bromide inhibits subepithelial fibrosis by reducing TGF-β1 in a chronic mouse model of allergic asthma. Int Arch Allergy Immunol 2015;167:110-118.
26.
Roderick JE, Gonzalez-Perez G, Kuksin CA, Dongre A, Roberts ER, Srinivasan J, Andrzejewski C Jr, Fauq AH,Golde TE, MieleL, Minter LM: Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemia. J Exp Med 2013;210:1311-1329.
27.
Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, de Stanchina E, Sulis ML, Barnes K, Sawai C, Homminga I, Meijerink J, Aifantis I, Basso G, Cordon-Cardo C, Ai W, Ferrando A: γ-Secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 2009;15:50-58.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.